Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
6.89 HKD | +0.44% | +1.92% | +3.14% |
04-15 | Ocumension Therapeutics Completes Phase III Trials for Postoperative Inflammation Drug | MT |
04-15 | Ocumension Therapeutics Announces Phase III Clinical Trial of OT-502 in China | CI |
ETFs positioned on Ocumension Therapeutics
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
1.59% | 4 M€ | -27.92% | ||
0.00% | 34 M€ | +4.25% | - |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+3.14% | 609M | |
+42.72% | 750B | |
+34.11% | 606B | |
-6.21% | 356B | |
+18.84% | 326B | |
+6.31% | 286B | |
+18.43% | 246B | |
-3.31% | 213B | |
+11.30% | 213B | |
+2.24% | 167B |
- Stock Market
- Equities
- 1477 Stock
- Funds and ETFs Ocumension Therapeutics